Conjugates of biologically active proteins having a modified in vivo half-life

Details for Australian Patent Application No. 2006208199 (hide)

Owner Cell Therapeutics, Inc.

Inventors Besman, Marc; Singer, Jack; Leung, David; Chipman, Stewart

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006208199

PCT Pub. Number WO2006/081249

Priority 60/647,119 25.01.05 US; 60/712,585 30.08.05 US

Filing date 25 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 7 June 2012

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081249 Priority application(s): WO2006/081249

7 June 2012 Application Accepted

  Published as AU-B-2006208199

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208201-Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin3-yl)-isoindole-1-3-dione

2006208198-Cancer markers and detection methods